JP Patent

JP5107576B2 — Ｇａｂａ類似体のプロドラッグを使用する不穏下肢症候群の治療または予防

Assigned to ゼノポート，インコーポレイティド · Expires 2012-12-26 · 13y expired

What this patent protects

Patent listed against Horizant.

Drugs covered by this patent

Horizant (GABAPENTIN ENACARBIL) · Azurity

Patent Metadata

Patent number: JP5107576B2
Jurisdiction: JP
Classification: —
Expires: 2012-12-26
Drug substance claim: No
Drug product claim: No
Assignee: ゼノポート，インコーポレイティド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.